Similar Articles
Avocatin B: Its Role in Cancer and Diabetes Mellitus Treatment
Aslı Melike Ekmekçi,Arzu Kasabalı, Oytun Erbaş
DOI: 10.5606/jebms.2023.1039
Issue: 2023, Volume 4 - Issue 1
2676
1687
The Metabolic Syndrome: A Cancer Risk Factor?
Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş
DOI: 10.5606/jebms.2023.1040
Issue: 2023, Volume 4 - Issue 1
824
674
Emerging Immunotherapeutic Approaches for Managing Metastasis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2023.1050
Issue: 2023, Volume 4 - Issue 2
731
584
Regulatory T Cells and Their Implications in Cancer Immunotherapy
Saime Sıla Gemici, Oytun Erbaş
DOI: 10.5606/jebms.2023.1064
Issue: 2023, Volume 4 - Issue 3
507
502
Cancer Stem Cells
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1083
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
637
448
Stem Cell Therapy in Cancer
Ayça Nur Demir, Oytun Erbaş
DOI: 10.5606/jebms.2024.1084
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
551
435
Enteral Nutrition in Cancer Patients
Gamze Nur Yüksel, Oytun Erbaş
DOI: 10.5606/jebms.2024.1089
Issue: 2024, Volume 5 - Issue 2
491
548
Coffee Intake and Cancer Risk: Exploring the Relationship
Zehra Betül Aydın, Oytun Erbaş
DOI: 10.5606/jebms.2024.1091
Issue: 2024, Volume 5 - Issue 2
535
551
Aspirin and NSAIDs as Cancer Preventive Agents: A Review
Nadin Bedikyan, Oytun Erbaş
DOI: 10.5606/jebms.2024.1093
Issue: 2024, Volume 5 - Issue 2
501
560
HERG1 and Cancer: Exploring the Nexus Between Ion Channels and Tumorigenesis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1100
Issue: 2024, Volume 5 - Issue 4
228
241
The Role of STAT3 in Cancer Development and Progression
Gökçen Kılınç, Oytun Erbaş
DOI: 10.5606/jebms.2024.1101
Issue: 2024, Volume 5 - Issue 4
195
257
Histone Deacetylase Inhibitors in Cancer Treatment
Şule Demirkasaoğlu, Oytun Erbaş
DOI: 10.5606/jebms.2024.1102
Issue: 2024, Volume 5 - Issue 4
227
236